Profil bibliographique

Andrea Malgeri

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

34Publications signalées

191Citations signalées

3Affiliations récentes

Institutions déclarées

Università Campus Bio-Medico National Cancer Institute Campus Bio Medico University Hospital

Domaines associés

Renal cell carcinoma treatmentCancer Immunotherapy and BiomarkersFerroptosis and cancer prognosisBladder and Urothelial Cancer TreatmentsProstate Cancer Diagnosis and Treatment

Publications récentes

Accès ouvert 2026 reviewOpenAlex

Molecular biomarkers in metastatic clear cell renal cell carcinoma treated with first-line immune combinations: a systematic review of phase III randomized clinical trials by Meet-URO group

Anna Amela Valsecchi, Michele Maffezzoli, Maria Concetta Cursano, Fabrizio Di Costanzo et autres

0 citationsCancer and Metastasis Reviews

2026 conference-abstractOpenAlex

Magnitude and timing of clinical benefit associated with pathologic complete response in perioperative muscle-invasive bladder cancer: A reconstructed IPD analysis of NIAGARA trial.

Andrea Malgeri, Alessio Cortellini, Linda Cerbone, Brigida Anna Maiorano et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2026 articleOpenAlex

Ketogenic and Low-Carbohydrate Diets in Prostate Cancer: Metabolic Rationale, Preclinical Evidence, and Preliminary Clinical Data

Silvia Manfrini, Andrea Malgeri, Carmine Mone, Ludovica Di Francesco et autres

2 citationsJournal of Clinical Medicine

2026 conference-abstractOpenAlex

A provocative analysis of first-line strategies in advanced urothelial carcinoma: Reconstructed individual patient data comparisons of EV–pembrolizumab, avelumab maintenance, and nivolumab–cisplatin–gemcitabine from their pivotal phase 3 trials.

Andrea Malgeri, Linda Cerbone, Maria Bassanelli, Claudia Mosillo et autres

0 citationsJournal of Clinical Oncology

Accès ouvert 2026 articleOpenAlex

Impact of bone-targeting agents on the clinical outcomes in patients with metastatic renal cell carcinoma treated with nivolumab: a sub-analysis of the Meet-URO 15 study

F. Pantano, Andrea Malgeri, Ugo De Giorgi, M. Maruzzo et autres

0 citationsFrontiers in Oncology

2026 articleOpenAlex

Diete chetogeniche e a basso contenuto di carboidrati nel cancro alla prostata: aspetti metabolici, studi preclinici e prospettive cliniche emergenti

Silvia Manfrini, Andrea Malgeri, Carmine Mone, Ludovica Di Francesco et autres

0 citationsL Endocrinologo

Accès ouvert 2025 articleOpenAlex

Osimertinib-Induced Lung Injury and Treatment Rechallenge: Clinical Insights From a Case Report With a Comprehensive Literature Review

Fabrizio Citarella, Emanuele Claudio Mingo, M. Fiorenti, Marco Russano et autres

0 citationsClinical Lung Cancer

Accès ouvert 2025 articleOpenAlex

Immune Checkpoint Inhibitors for Patients With Preexisting Autoimmune Neurologic Disorders

Kylie Fletcher, Marc Machaalani, Razane El Hajj Chehade, Amin H. Nassar et autres

20 citationsJAMA Network Open

2024 articleOpenAlex

Prognostic Impact of IMDC Category Shift From Baseline to Nivolumab Initiation in Metastatic Renal Cell Carcinoma: A Sub-Analysis of the MEET-URO 15 Study

Brigida Anna Maiorano, Martina Catalano, Chiara Mercinelli, Giandomenico Roviello et autres

3 citationsClinical Genitourinary Cancer

Accès ouvert 2024 articleOpenAlex

Prognostic value of type of prior TKI in pretreated metastatic renal cell carcinoma patients receiving nivolumab

Alessandra Damassi, Malvina Cremante, Alessio Signori, Sara Elena Rebuzzi et autres

1 citationImmunotherapy

Accès ouvert 2024 articleOpenAlex

Outcomes of First-Line Abiraterone Acetate or Enzalutamide for Older Adults With Metastatic Castration-Resistant Prostate Cancer According to Use of Upfront Docetaxel for Metastatic Castration-Sensitive Prostate Cancer in an International Multicenter Registry: A SPARTACUSS—Meet-URO 26 Study

Giuseppe Fotia, Calogero Saieva, Richard M. Lee‐Ying, Anna Patrikidou et autres

0 citationsClinical Genitourinary Cancer

Accès ouvert 2024 articleOpenAlex

A red blood cell-based score in the prognostication of patients with metastatic RCC of the Meet-URO 15 study

Shobana Anpalakhan, Giuseppe Luigi Banna, Sara Elena Rebuzzi, Giuseppe Fornarini et autres

3 citationsImmunotherapy

Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.